Forward Ventures
Forward Ventures is a San Diego-based life science venture capital firm founded in 1990, managing over $450 million across five funds and having invested in more than 60 biopharmaceutical companies at all development stages.
- Company typePrivate
- Founded1990
- HeadquartersSan Diego, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Forward Ventures does
Forward Ventures is a life science venture capital firm founded in 1990 and headquartered in San Diego, California. The firm manages over $450 million in assets across five (and according to one source, six) venture funds, and has invested in more than 60 life science companies over its roughly 30-year history. Its primary investment focus is biopharmaceutical therapeutics at all stages of company development, from startup through IPO or trade sale, with the most recent fund concentrating on products in early clinical development. The firm pursues companies developing innovative therapies for unmet medical needs across oncology, anti-infectives, immunology, and neurological diseases.
The firm operates a traditional venture capital business model, generating revenue through management fees charged on assets under management and carried interest realized when portfolio companies exit via IPO or acquisition. Forward Ventures has a hands-on investment approach, deploying capital in a disciplined, often tranched manner tied to clearly defined milestones, and partners take board leadership positions at portfolio companies. The investment team — led by Founding Managing Partner Standish Fleming — provides strategic planning support, helps identify key management hires, assists with financing rounds and IPO preparation, and manages exits. Notable exits include acquisitions by Gilead (2003), GSK (2005), DuPont (2007), Merck (2007), Lilly (2007), Amgen (2012, 2013), Takeda (2012), Daiichi Sankyo (2014), and Debiopharm (2014), plus multiple IPOs including Syndax (2016). The firm has sourced assets and technologies globally while investing primarily throughout the United States.
As of the most recent public materials (website copyright 2019), Forward Ventures is focused on maximizing the value of its existing portfolio and is not accepting new business plans, signaling a transition to portfolio harvest mode.
Forward Ventures firmographics
Firmographics- Name
- Forward Ventures
- Legal name
- Forward Ventures
- Website
- https://forwardventures.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Forward Ventures is a San Diego-based life science venture capital firm founded in 1990, managing over $450 million across five funds and having invested in more than 60 biopharmaceutical companies at all development stages.
- Ownership category
- akta.pro rank
Forward Ventures industry classification
Industry- Product category
- Life Science Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
Keywords
Where Forward Ventures is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Forward Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Management Fees and Carried Interest: Forward Ventures generates revenue through traditional venture capital mechanisms: management fees charged on assets under management, and carried interest (performance fees) realized when portfolio companies achieve exits through IPO or acquisition.
Marketing channels2 records
Forward Ventures product offering
Product offeringCore offering
Forward Ventures is a life-science venture capital firm founded in 1990 that invests in biopharmaceutical therapeutics companies at all stages of development, from startup through IPO or trade sale. The firm manages over $450 million across five funds, has invested in over 60 companies, and provides capital plus hands-on strategic, operational, and board-level support to portfolio company founders and management teams.
Product overview
Forward Ventures is a life-science venture capital firm that provides investment services rather than traditional products. The firm manages over $450 million across five funds and has invested in over 60 life science companies. Their core offering is venture capital investment in biopharmaceutical therapeutics companies at all stages of development, from startup through IPO or trade sale. They focus on companies developing innovative therapies for unmet medical needs, providing capital, strategic guidance, and operational support to founders and management teams.
Differentiator
Problem solved
Functional benefit
Products and services
- Forward Ventures Venture Capital Funds
- Portfolio Company Strategic Support
Companies that use Forward Ventures
Customer profileSegments2 records
Ideal customer profiles2 records
Forward Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Forward Ventures partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights3 records
Forward Ventures competitors and assessment
Company assessmentDirect peers
- 5AM Ventures: An early-stage life science venture firm focused on building biotech companies from platform technologies and scientific founders. Directly comparable to Forward Ventures on early-clinical biopharma focus, founder creation, and hands-on board model.
- Domain Associates: A long-tenured San Diego-based venture capital firm investing in life sciences and healthcare. Highly comparable to Forward Ventures on geography, sector focus, stage (early through late clinical), and multi-fund life science strategy.
- Versant Ventures: A healthcare-focused venture firm investing across biopharmaceuticals, medical devices, and diagnostics from seed through late stage. Comparable to Forward Ventures on life science sector, multi-stage approach, and founder-building model with operating partners.
- Atlas Venture: An early-stage biotech venture firm building companies from inception around innovative therapeutics. Highly comparable to Forward Ventures' seed-from-scratch, biopharma-focused model with strong operating-partner involvement.
- OrbiMed: A leading healthcare-dedicated investment firm with multi-fund life science strategies across all stages. Comparable to Forward Ventures on biopharma focus, multi-fund structure, and biotech board leadership.
- ARCH Venture Partners: A venture firm founded to invest early in life sciences and physical sciences companies from university and research sources. Highly comparable on early-stage life science focus, founder creation, and long-dated multi-fund model.
- SV Health Investors: A healthcare and life sciences venture firm with multiple dedicated biotech funds investing across all stages. Comparable to Forward Ventures on sector specialization, multi-fund structure, and biotech exits.
- Abingworth: A life sciences-focused investment firm with venture and growth strategies across biotech and medtech. Comparable to Forward Ventures on dedicated life science focus, multi-stage approach, and clinical-stage biopharma emphasis.
Broad incumbents
- New Enterprise Associates (NEA): A large multi-stage venture firm with a significant healthcare/biotech practice investing from seed through growth. Comparable to Forward Ventures on life science sector and stage breadth, but operates as a much broader generalist with significantly larger AUM.
Regional players
- Bracewell Capital Partners: A San Diego-rooted venture firm investing across technology and life science stages. Comparable to Forward Ventures on San Diego base and life science exposure, though broader in sector focus than Forward Ventures' biopharma-only mandate.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Forward Ventures social profiles
Digital presenceForward Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Forward Ventures leadership team
Management profileNumber of profiles
Profiles2 records
Forward Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Forward Ventures M&A and investment
M&A and investmentM&A
Investments65 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Forward Ventures
What does Forward Ventures do?
Forward Ventures is a life-science venture capital firm founded in 1990 that invests in biopharmaceutical therapeutics companies at all stages of development, from startup through IPO or trade sale. The firm manages over $450 million across five funds, has invested in over 60 companies, and provides capital plus hands-on strategic, operational, and board-level support to portfolio company founders and management teams.
Is Forward Ventures a public or private company?
Forward Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Forward Ventures founded?
Forward Ventures was founded in 1990. It employs 51 to 100 people.
Where is Forward Ventures based?
Forward Ventures is headquartered in San Diego, United States, in the North America region.
How does Forward Ventures make money?
One revenue line is on record: management Fees and Carried Interest.
Who are Forward Ventures's main competitors?
Direct peers on record are 5AM Ventures, Domain Associates, Versant Ventures, Atlas Venture, OrbiMed, ARCH Venture Partners, SV Health Investors and Abingworth. New Enterprise Associates (NEA) is listed as a broad incumbent. Bracewell Capital Partners is listed as a regional player.
Does Forward Ventures have an API?
No public API is recorded for Forward Ventures.
What industry is Forward Ventures in?
Forward Ventures's product category is Life Science Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 52394 and its SIC code is 6282.